net_left Kdata Phương Thức Thanh Toán

Moderna signs $35 million deal with cancer drug developer CytomX

06 Tháng Giêng 2023
Moderna signs $35 million deal with cancer drug developer CytomX © Reuters. FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
let atwWrapper,atwContainerWidth,atwSliderBox,atwTotalWidth; function initATWSlider() { atwWrapper = $('.relatedInstruments'); atwSliderBox = atwWrapper.find('.slider'); atwContainerWidth = atwWrapper.width(); atwTotalWidth = atwSliderBox.width(); if(window.domainId === '2' || window.domainId === '3'){ atwWrapper.find('.sliderRight').addClass('js-slider-prev'); atwWrapper.find('.sliderLeft').addClass('js-slider-next'); } else { atwWrapper.find('.sliderRight').addClass('js-slider-next'); atwWrapper.find('.sliderLeft').addClass('js-slider-prev'); } if(atwSliderBox.find('.instrumentBox').length > 6){ atwWrapper.find('.js-slider-next').fadeIn(600); } } function atwMoveRight() { atwWrapper.find('.js-slider-prev').fadeIn(150); $(".slider > :visible:first").hide(150) $(".slider > :visible:last").next().show(150); if(!$(".slider > :visible:last").next().find('.name')()){ atwWrapper.find('.js-slider-next').fadeOut(150); return; } } function atwMoveLeft() { atwWrapper.find('.js-slider-next').fadeIn(150); $(".slider > :visible:last").hide(150); $(".slider > :visible:first").prev().show(150); if(!$(".slider > :visible:first").prev().find('.name')()){ atwWrapper.find('.js-slider-prev').fadeOut(150); return; } } initATWSlider(); //update star icon on adding/removing instrument to/from specific watchlist atwWrapper.on('click', 'label.addRow', function() { let parent = $(this).parent(); let checkedPortfolio = false; parent.find('input[type=checkbox]').each(function () { if($(this).is(':checked')){ checkedPortfolio = true; } }); let closestStar = $(this).closest('.addToPortWrapper').find('.star'); if(checkedPortfolio){ closestStar.addClass('added'); }else{ closestStar.removeClass('added'); } }); //update star icon on creating new watchlist atwWrapper.find('.js-create-watchlist-portfolio').find('a.js-create').on('click',function () { let parent = $(this).parent(); let watchlistName = parent.find('input[type=text]').val(); if(!watchlistName){ return; } let star = $(this).closest('.addToPortWrapper').find('.star'); star.addClass('added'); }); //update star icon on adding new position atwWrapper.find('.js-create-holdings-portfolio').find('.js-submit').on('click',function () { let addPositionForm = $(this).closest('.addToPortfolioPop').find('.holdingsContent'); let amount = addPositionForm.find('.js-amount').val(); if(amount < 1){ return; } let star = $(this).closest('.addToPortWrapper').find('.star'); star.addClass('added'); }); atwWrapper.find('.instrumentBox').find('.shortInfo').on('click',function () { if(!window.ga){ return; } let pairId = $(this).parent().find('.js-add-to-portfolio').attr('data-pair-id'); let pairType = window.atwPairTypes[pairId]; window.ga('allSitesTracker.send', 'event', 'content', 'symbol link clicked', '', { "dimension147":"symbol_link_clicked", "dimension163":"click", "dimension148":"symbol", "dimension162":"content add to watchlist", "dimension161":"article page", "dimension142":"article", "dimension75":pairType, "dimension138":pairId, "dimension118":"2974229" }); window.open($(this).attr('data-href')); }); window.atwPairTypes = {"960580":"Equities","1114321":"Equities"};

(Reuters) - Moderna (NASDAQ:MRNA) Inc on Thursday announced a $35 million licensing deal with cancer-focused drug developer CytomX Therapeutics (NASDAQ:CTMX) to work on messenger RNA-based therapies for a wide range of diseases.

Shares of California-based CytomX rose more than 50% in extended trading.

The firm will get $5 million in prepaid research funding as part of the upfront payment and it is eligible for up to about $1.2 billion in future milestone payments, the companies said in a joint statement.

The news comes a month after an experimental cancer vaccine from Moderna based on mRNA technology was shown to work against a type of skin cancer.

The deal offers CytomX access to Moderna's mRNA technology, which has been used to develop COVID-19 vaccines, while Moderna would get access to CytomX's Probody platform, used in the development of cancer therapies targeting diseased tissues.

Moderna said it will also pay tiered royalties to CytomX on global sales of any products which enter the market under the deal. The agreement also provides the biotech company the option to participate in a future equity financing by CytomX.

The companies will work together to discover experimental therapies and Moderna will be responsible for human trials and commercial activities of products.

An mRNA-based therapy or vaccine works by instructing human cells to produce proteins that can spur the immune system into action.

Để lại bình luận
Hot Auto Trade Bot Phương Thức Thanh Toán
BROKERS ĐƯỢC CẤP PHÉP
net_home_top Ai VIF
30-05-2023 08:49:12 (UTC+7)

EUR/USD

1.0722

+0.0003 (+0.03%)

Summary

Neutral

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (2)

Sell (6)

EUR/USD

1.0722

+0.0003 (+0.03%)

Summary

Neutral

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (2)

Sell (6)

GBP/USD

1.2373

+0.0033 (+0.27%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (5)

Sell (3)

USD/JPY

140.06

-0.55 (-0.39%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (5)

Sell (3)

AUD/USD

0.6552

+0.0030 (+0.46%)

Summary

Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (4)

Sell (4)

USD/CAD

1.3573

-0.0038 (-0.28%)

Summary

Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (1)

Sell (5)

EUR/JPY

150.17

-0.58 (-0.38%)

Summary

↑ Buy

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (6)

Sell (2)

EUR/CHF

0.9687

-0.0022 (-0.23%)

Summary

Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (1)

Sell (4)

Gold Futures

1,962.05

-1.05 (-0.05%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (2)

Sell (5)

Silver Futures

23.308

-0.052 (-0.22%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (3)

Sell (2)

Copper Futures

3.6833

+0.0013 (+0.04%)

Summary

Buy

Moving Avg:

Buy (11)

Sell (1)

Indicators:

Buy (3)

Sell (3)

Crude Oil WTI Futures

73.21

+0.54 (+0.74%)

Summary

Neutral

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (2)

Sell (7)

Brent Oil Futures

77.41

+0.43 (+0.56%)

Summary

Neutral

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (2)

Sell (6)

Natural Gas Futures

2.357

-0.060 (-2.48%)

Summary

Neutral

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (0)

Sell (3)

US Coffee C Futures

180.75

-1.95 (-1.07%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

Euro Stoxx 50

4,320.01

+50.37 (+1.18%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (2)

S&P 500

4,205.45

+54.17 (+1.30%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (2)

Sell (9)

DAX

15,952.73

-31.24 (-0.20%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (4)

Sell (1)

FTSE 100

7,627.20

+56.33 (+0.74%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (0)

Sell (8)

Hang Seng

18,646.50

+95.39 (+0.51%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

US Small Cap 2000

1,773.02

+18.42 (+1.05%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (7)

Sell (0)

IBEX 35

9,180.10

-11.00 (-0.12%)

Summary

↑ Buy

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (7)

Sell (1)

BASF SE NA O.N.

46.705

-0.205 (-0.44%)

Summary

Neutral

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (1)

Sell (7)

Bayer AG NA

54.35

-0.05 (-0.09%)

Summary

Buy

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (5)

Sell (4)

Allianz SE VNA O.N.

207.75

+0.35 (+0.17%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (10)

Sell (0)

Adidas AG

154.32

-1.12 (-0.72%)

Summary

Sell

Moving Avg:

Buy (5)

Sell (7)

Indicators:

Buy (2)

Sell (5)

Deutsche Lufthansa AG

9.196

-0.026 (-0.28%)

Summary

Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (3)

Sell (3)

Siemens AG Class N

156.00

-0.68 (-0.43%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (7)

Deutsche Bank AG

9.690

-0.052 (-0.53%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

    EUR/USD 1.0722 Neutral  
    GBP/USD 1.2373 ↑ Buy  
    USD/JPY 140.06 Neutral  
    AUD/USD 0.6552 Buy  
    USD/CAD 1.3573 Sell  
    EUR/JPY 150.17 ↑ Buy  
    EUR/CHF 0.9687 Sell  
    Gold 1,962.05 Neutral  
    Silver 23.308 ↑ Buy  
    Copper 3.6833 Buy  
    Crude Oil WTI 73.21 Neutral  
    Brent Oil 77.41 Neutral  
    Natural Gas 2.357 Neutral  
    US Coffee C 180.75 ↑ Sell  
    Euro Stoxx 50 4,320.01 ↑ Buy  
    S&P 500 4,205.45 ↑ Sell  
    DAX 15,952.73 Neutral  
    FTSE 100 7,627.20 ↑ Sell  
    Hang Seng 18,646.50 ↑ Buy  
    Small Cap 2000 1,773.02 ↑ Buy  
    IBEX 35 9,180.10 ↑ Buy  
    BASF 46.705 Neutral  
    Bayer 54.35 Buy  
    Allianz 207.75 ↑ Buy  
    Adidas 154.32 Sell  
    Lufthansa 9.196 Sell  
    Siemens AG 156.00 ↑ Sell  
    Deutsche Bank AG 9.690 ↑ Buy  
Mua/Bán 1 chỉ SJC
# So hôm qua # Chênh TG
SJC Eximbank6,640/ 6,680
(0/ 0) # 1,142
SJC HCM6,635/ 6,695
(-5/ -5) # 1,157
SJC Hanoi6,635/ 6,697
(-5/ -5) # 1,159
SJC Danang6,635/ 6,697
(-5/ -5) # 1,159
SJC Nhatrang6,635/ 6,697
(-5/ -5) # 1,159
SJC Cantho6,635/ 6,697
(-5/ -5) # 1,159
Cập nhật 30-05-2023 08:49:15
Xem lịch sử giá vàng SJC: nhấn đây!
ↀ Giá vàng thế giới
$1,944.36 +0.39 0.02%
Live 24 hour Gold Chart
ʘ Giá bán lẻ xăng dầu
Sản phẩm Vùng 1 Vùng 2
RON 95-V22.27022.710
RON 95-III21.49021.910
E5 RON 92-II20.48020.880
DO 0.05S17.95018.300
DO 0,001S-V18.81019.180
Dầu hỏa 2-K17.96018.310
ↂ Giá dầu thô thế giới
WTI $73.22 -7.31 -0.09%
Brent $77.37 -7.26 -0.09%
$ Tỷ giá Vietcombank
Ngoại tệMua vàoBán ra
USD23.280,0023.650,00
EUR24.502,2825.874,28
GBP28.257,0829.461,99
JPY162,61172,15
KRW15,3518,70
Cập nhật lúc 08:44:00 30/05/2023
Xem bảng tỷ giá hối đoái
Phương Thức Thanh Toán